The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment

Overview of attention for article published in Trials, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

news: 2 news outlets

twitter: 16 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 83 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

What’s Going to Be Hot at ESC 2022?

TCTMD, 22 Aug 2022

DELIVER, testing dapagliflozin in HFpEF, is a big draw, but there’s also buzz for REVIVED, INVICTUS, and early-stage drug trials.

ESC 2022 : les études à ne pas manquer

Medscape, 16 Aug 2022

Le blog du Pr Gabriel Steg – Cardiologue TRANSCRIPTION France, Espagne __ Bonjour.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.